Evolution of the Average Target: BioRestorative Therapies, Inc.

Evolution of the Target Price: BioRestorative Therapies, Inc.

Changes in Analyst Recommendations: BioRestorative Therapies, Inc.

078cd3ee1ceede14a.UG-_IGzi0ApnFB9v9oTve25qFU6fnzRXfbnUBk9nkLc.CSfLEzuPk0UoJXcVou69KAAnOBbt8HwgFuCCYA4_w_IqKYpXAdGgfwByUg~4b09349a132a653cf69c81e8667c37ec

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +2,900.75%
+17.07%
+22.32%
+31.93%
+88.4%
+22.04%
+25.37%
+11.53%
-3.74%
-7.86%
Average +310.78%
Weighted average by Cap. +24.55%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2666USD
Average target price
8.000USD
Spread / Average Target
+2,900.75%
High Price Target
15.00USD
Spread / Highest target
+5,526.41%
Low Price Target
1.000USD
Spread / Lowest Target
+275.09%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Roth Capital Partners
Maxim
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2666USD
Average target price
8.000USD
Spread / Average Target
+2,900.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BRTX Stock
  4. Consensus BioRestorative Therapies, Inc.